Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Embattled Alzheimer’s Researcher Is Charged With Fraud
Hoau-Yan Wang, a professor at City College, published studies supporting [...]
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, [...]
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked [...]
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s
People with two copies of the gene variant APOE4 are [...]
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, [...]
¿Se puede tener alzhéimer y no presentar síntomas?
Una propuesta para cambiar los lineamientos de detección de la [...]
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the [...]